|
posters
Resistance
to New Antiretroviral Agents
Synthesis
and anti-HIV activity of enantiomerically pure D-FDOC
DC Liotta
Characterization
of baseline and treatment-emergent resistance mutations following
1 year of therapy on an entirely once a day regimen including
emtricitabine
K Borroto-Esoda
Characterization
of HIV-1 showing decreased susceptibility to tipranavir and
their inhibition by tipranavir-containing drug mixtures
L Doyon
In
vitro cross resistance profile of RO033-4649 against a panel
of multiply-substituted protease inhibitor-resistant viruses:
role of common protease resistance mutations
G Heilek-Snyder
Antiviral
activity of P-1946, a novel anti-HIV protease inhibitor
G Sévigny
Baseline
and on-treatment gp41 genotype and susceptibility to enfuvirtide
(ENF) and T-1249 in a 10-day study of T-1249 in patients failing
an ENF-containing regimen (T1249-102)
GD Miralles
Human
ß-defensins inhibit HIV-1 replication in vitro
ME Quiñones-Mateu
Viral resistance
against a candidate HIV microbicide
Z Ambrose
|
